Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom’s COVID-19 Public Health Response
Otter AD., Bown A., D’Arcangelo S., Bailey D., Semper A., Hewson J., Catton M., Perumal P., Sweed A., McKee DF., Jones J., Harvala H., Lamikanra A., Zambon M., Andrews N., Whitaker H., Linley E., Mentzer AJ., Skelly D., Knight JC., Klenerman P., Amirthalingam G., Taylor S., Rowe C., Vipond R., Brooks T.
Serology assays have been useful in determining those with previous SARS-CoV-2 infection in a wide range of research and serosurveillance projects. However, assays vary in their sensitivity at detecting SARS-CoV-2 antibodies. Here, we detail an extended evaluation and characterization of the Euroimmun anti-SARS-CoV-2 IgG assay, one that has been widely used within the United Kingdom on over 160,000 samples.